Showing results (161-170 of 204) with videos related to
Sort By:
Pageof 21
Biological Reviews of the Cambridge Philosophical Society|April 19, 2023
Hypotheses in urban ecology: building a common knowledge baseSophie Lokatis, Jonathan M Jeschke, Maud Bernard-Verdier, et al.Frontiers in Ecology and the Environment|July 25, 2022
From meta-system theory to the sustainable management of rivers in the AnthropoceneNúria Cid, Tibor Erős, Jani Heino, et al.Sustainability Science|April 4, 2023
Capacity of countries to reduce biological invasionsGuillaume Latombe, Hanno Seebens, Bernd Lenzner, et al.Ecosphere (Washington, D.C)|December 23, 2021
Mechanistic reconciliation of community and invasion ecologyGuillaume Latombe, David M Richardson, Melodie A McGeoch, et al.Leukemia & Lymphoma|October 15, 2015
Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacyThomas E Lew, Chan Y Cheah, Dennis A Carney, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup studyMarinus H J van Oers, Martine Van Glabbeke, Livia Giurgea, et al.Global Change Biology|October 1, 2020
Projecting the continental accumulation of alien species through to 2050Hanno Seebens, Sven Bacher, Tim M Blackburn, et al.Trends in Ecology & Evolution|February 19, 2022
Societal extinction of speciesIvan Jarić, Uri Roll, Marino Bonaiuto, et al.Leukemia & Lymphoma|February 15, 2011
Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology GroupAndrew Wirth, Andrew Grigg, Max Wolf, et al.Proceedings. Biological Sciences|March 5, 2020
Rethinking megafaunaMarcos Moleón, José A Sánchez-Zapata, José A Donázar, et al.Pageof 21